{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:12:15Z","timestamp":1792843935505,"version":"4.5.0"},"reference-count":189,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05740-4","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T03:57:33Z","timestamp":1732507053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["The role of mitochondria in iron overload-induced damage"],"prefix":"10.1186","volume":"22","author":[{"given":"Yangyang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"5740_CR1","doi-asserted-by":"crossref","unstructured":"PONKA P. Cell Biology of Heme [J]. Am J Med Sci, 1999, 318(4): 241\u201356.","DOI":"10.1016\/S0002-9629(15)40628-7"},{"key":"5740_CR2","doi-asserted-by":"crossref","unstructured":"PAUL V D, LILL R. Biogenesis of cytosolic and nuclear iron-sulfur proteins and their role in genome stability [J]. Biochim Biophys Acta, 2015, 1853(6): 1528\u201339.","DOI":"10.1016\/j.bbamcr.2014.12.018"},{"key":"5740_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cca.2020.12.005","volume":"513","author":"J GAO","year":"2021","unstructured":"GAO J, ZHOU Q, WU D, et al. Mitochondrial iron metabolism and its role in diseases [J]. Clin Chim Acta. 2021;513:6\u201312.","journal-title":"Clin Chim Acta"},{"issue":"11","key":"5740_CR4","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.cmet.2022.10.008","volume":"34","author":"M PICARD","year":"2022","unstructured":"PICARD M, SHIRIHAI O S. Mitochondrial signal transduction [J]. Cell Metabol. 2022;34(11):1620\u201353.","journal-title":"Cell Metabol"},{"issue":"7","key":"5740_CR5","doi-asserted-by":"publisher","first-page":"112728","DOI":"10.1016\/j.celrep.2023.112728","volume":"42","author":"AR AL AMIR DACHE Z, THIERRY","year":"2023","unstructured":"AL AMIR DACHE Z, THIERRY AR. Mitochondria-derived cell-to-cell communication [J]. Cell Rep. 2023;42(7):112728.","journal-title":"Cell Rep"},{"issue":"1","key":"5740_CR6","doi-asserted-by":"publisher","first-page":"112515","DOI":"10.1016\/j.yexcr.2021.112515","volume":"400","author":"Y SEKINE","year":"2021","unstructured":"SEKINE Y, HOUSTON R. Cellular metabolic stress responses via organelles [J]. Exp Cell Res. 2021;400(1):112515.","journal-title":"Exp Cell Res"},{"issue":"7483","key":"5740_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature12985","volume":"505","author":"FRIEDMANJR NUNNARI","year":"2014","unstructured":"NUNNARI FRIEDMANJR. Mitochondrial form and function [J]. Nature. 2014;505(7483):335\u201343.","journal-title":"Nature"},{"issue":"5684","key":"5740_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1126\/science.1099320","volume":"305","author":"DR GREEN","year":"2004","unstructured":"GREEN DR. The pathophysiology of mitochondrial cell death [J]. Science. 2004;305(5684):626\u20139.","journal-title":"Science"},{"issue":"6","key":"5740_CR9","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.cell.2012.02.035","volume":"148","author":"J NUNNARI","year":"2012","unstructured":"NUNNARI J, Mitochondria SUOMALAINENA. Sickness and in health [J]. Cell. 2012;148(6):1145\u201359.","journal-title":"Cell"},{"key":"5740_CR10","first-page":"38","volume":"5","author":"MT URRUTIA P J, MENA N P, N\u00c3\u00ba\u00c3\u00b1EZ","year":"2014","unstructured":"URRUTIA P J, MENA N P, N\u00c3\u00ba\u00c3\u00b1EZ MT. The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders [J]. Front Pharmacol. 2014;5:38.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5740_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00395-023-00990-7","volume":"118","author":"N FEFELOVA","year":"2023","unstructured":"FEFELOVA N, WONGJAIKAM S, PAMARTHI S H, et al. Deficiency of mitochondrial calcium uniporter abrogates iron overload-induced cardiac dysfunction by reducing ferroptosis [J]. Basic Res Cardiol. 2023;118(1):21.","journal-title":"Basic Res Cardiol"},{"issue":"0","key":"5740_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neuro.2021.11.003","volume":"88","author":"R CHENG","year":"2022","unstructured":"CHENG R, DHORAJIA V V, KIM J, et al. Mitochondrial iron metabolism and neurodegenerative diseases [J]. Neurotoxicology. 2022;88(0):88\u2013101.","journal-title":"Neurotoxicology"},{"issue":"0","key":"5740_CR13","first-page":"1","volume":"2022","author":"F YAN","year":"2022","unstructured":"YAN F, LI K, XING W, et al. Role of Iron-related oxidative stress and mitochondrial dysfunction in Cardiovascular diseases [J]. Oxidative Med Cell Longev. 2022;2022(0):1\u201312.","journal-title":"Oxidative Med Cell Longev"},{"key":"5740_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2014.03.039","volume":"72","author":"TD COATES","year":"2014","unstructured":"COATES TD. Physiology and pathophysiology of iron in hemoglobin-associated diseases [J]. Free Radic Biol Med. 2014;72:23\u201340.","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"5740_CR15","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1182\/blood-2003-03-0807","volume":"102","author":"W ESPOSITO B P, BREUER","year":"2003","unstructured":"ESPOSITO B P, BREUER W. Labile plasma iron in iron overload: redox activity and susceptibility to chelation [J]. Blood. 2003;102(7):2670\u20137.","journal-title":"Blood"},{"issue":"23","key":"5740_CR16","doi-asserted-by":"publisher","first-page":"16046","DOI":"10.1016\/S0021-9258(17)33971-6","volume":"269","author":"E W R","year":"1994","unstructured":"E W R, J G P, N F O, et al. Uptake of non-transferrin-bound iron by both reductive and nonreductive processes is modulated by intracellular iron [J]. J Biol Chem. 1994;269(23):16046\u201353.","journal-title":"J Biol Chem"},{"issue":"7","key":"5740_CR17","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/15353702221076397","volume":"247","author":"S KUMFU","year":"2022","unstructured":"KUMFU S, CHATTIPAKORN S C CHATTIPAKORNN. Iron overload cardiomyopathy: using the latest evidence to inform future applications [J]. Experimental Biology Med. 2022;247(7):574\u201383.","journal-title":"Experimental Biology Med"},{"issue":"7","key":"5740_CR18","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.1002\/jcp.30219","volume":"236","author":"S KUMFU","year":"2020","unstructured":"KUMFU S, SIRI-ANGKUL N, CHATTIPAKORN SC, et al. Silencing of lipocalin\u20102 improves cardiomyocyte viability under iron overload conditions via decreasing mitochondrial dysfunction and apoptosis [J]. J Cell Physiol. 2020;236(7):5108\u201320.","journal-title":"J Cell Physiol"},{"issue":"5","key":"5740_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s10741-018-9700-5","volume":"23","author":"R GORDAN","year":"2018","unstructured":"GORDAN R, WONGJAIKAM S. Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update [J]. Heart Fail Rev. 2018;23(5):801\u201316.","journal-title":"Heart Fail Rev"},{"issue":"5","key":"5740_CR20","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1182\/blood-2004-02-0630","volume":"104","author":"P POOTRAKUL","year":"2004","unstructured":"POOTRAKUL P, BREUER W. Labile plasma iron (LPI) as an indicator of chelatable plasma redox activity in iron-overloaded \u03b2-thalassemia\/HbE patients treated with an oral chelator [J]. Blood. 2004;104(5):1504\u201310.","journal-title":"Blood"},{"key":"5740_CR21","doi-asserted-by":"crossref","unstructured":"HUBERT N, HENTZE M W. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: Implications for regulation and cellular function [J]. Proceedings of the National Academy of Sciences. 2002, 99(19): 12345-50.","DOI":"10.1073\/pnas.192423399"},{"key":"5740_CR22","doi-asserted-by":"crossref","unstructured":"ZHANG S, XIN W, ANDERSON G J, et al. Double-edge sword roles of iron in driving energy production versus instigating ferroptosis [J]. Volume 13. Cell Death & Disease; 2022. p. 40. 1.","DOI":"10.1038\/s41419-021-04490-1"},{"issue":"8","key":"5740_CR23","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0891-5849(02)01006-7","volume":"33","author":"O KAKHLON","year":"2002","unstructured":"KAKHLON O, CABANTCHIK Z I. The labile iron pool: characterization, measurement, and participation in cellular processes1 1This article is part of a series of reviews on Iron and Cellular Redox Status. The full list of papers may be found on the homepage of the journal [J]. Free Radic Biol Med. 2002;33(8):1037\u201346.","journal-title":"Free Radic Biol Med"},{"issue":"3\u20134","key":"5740_CR24","first-page":"289","volume":"29","author":"T CHEN","year":"2023","unstructured":"CHEN T, LIANG L, WANG Y, et al. Ferroptosis and cuproptposis in kidney diseases: dysfunction of cell metabolism [J]. Apoptosis. 2023;29(3\u20134):289\u2013302.","journal-title":"Apoptosis"},{"issue":"7","key":"5740_CR25","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bbamcr.2006.05.013","volume":"1763","author":"PIETRANGELO A","year":"2006","unstructured":"PIETRANGELO A. Hereditary hemochromatosis [J]. Biochim Biophys Acta. 2006;1763(7):700\u201310.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"5740_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bcmd.2003.08.003","volume":"32","author":"PIETRANGELO A","year":"2004","unstructured":"PIETRANGELO A. The ferroportin disease [J]. Blood Cells Mol Dis. 2004;32(1):131\u20138.","journal-title":"Blood Cells Mol Dis"},{"issue":"10116","key":"5740_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","volume":"391","author":"MD TAHER A T, WEATHERALL D J, CAPPELLI","year":"2018","unstructured":"TAHER A T, WEATHERALL D J, CAPPELLINI MD. Thalassaemia [J]. Lancet (London England). 2018;391(10116):155\u201367.","journal-title":"Lancet (London England)"},{"key":"5740_CR28","doi-asserted-by":"crossref","unstructured":"MANCARDI D, MEZZANOTTE M, ARRIGO E, et al. Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver [J]. Antioxidants (Basel, Switzerland), 2021, 10(12):1864.","DOI":"10.3390\/antiox10121864"},{"issue":"4","key":"5740_CR29","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.hoc.2014.04.003","volume":"28","author":"JB PORTER","year":"2014","unstructured":"PORTER JB. The pathophysiology of Transfusional Iron overload [J]. Hematol Oncol Clin N Am. 2014;28(4):683\u2013701.","journal-title":"Hematol Oncol Clin N Am"},{"issue":"2","key":"5740_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12185-016-2002-6","volume":"104","author":"S ITO","year":"2016","unstructured":"ITO S, IKUTA K, KATO D, et al. In vivo behavior of NTBI revealed by automated quantification system [J]. Int J Hematol. 2016;104(2):175\u201381.","journal-title":"Int J Hematol"},{"key":"5740_CR31","doi-asserted-by":"crossref","unstructured":"PARISI S, FINELLI C. Prognostic factors and clinical considerations for Iron Chelation Therapy in Myelodysplastic Syndrome patients [J]. J Blood Med, 2021, 12: 1019\u201330.","DOI":"10.2147\/JBM.S287876"},{"issue":"3","key":"5740_CR32","first-page":"e2023178","volume":"94","author":"P TZOULIS","year":"2023","unstructured":"TZOULIS P, YAVROPOULOU M P BANCHEVA, et al. Recent advancements in glucose dysregulation and pharmacological management of osteoporosis in transfusion-dependent thalassemia (TDT): an update of ICET-A (International Network of clinicians for endocrinopathies in Thalassemia and Adolescence Medicine) [J]. Acta Biomed. 2023;94(3):e2023178.","journal-title":"Acta Biomed"},{"issue":"7","key":"5740_CR33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/17474086.2021.1935854","volume":"14","author":"J PORTER","year":"2021","unstructured":"PORTER J, TAHER A, VIPRAKASIT V, et al. Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in \u03b2-thalassemia: current evidence and future clinical development [J]. Expert Rev Hematol. 2021;14(7):633\u201344.","journal-title":"Expert Rev Hematol"},{"key":"5740_CR34","doi-asserted-by":"crossref","unstructured":"WOOD JC. Cardiac complications in Thalassemia throughout the lifespan: victories and challenges [J]. Volume 1530. Annals of the New York Academy of Sciences; 2023. pp. 64\u201373. 1.","DOI":"10.1111\/nyas.15078"},{"issue":"4","key":"5740_CR35","first-page":"e2022291","volume":"93","author":"M SOLIMAN A T, DE SANCTIS V, YASSIN","year":"2022","unstructured":"SOLIMAN A T, DE SANCTIS V, YASSIN M, et al. Blood transfusion and iron overload in patients with sickle cell disease (SCD): personal experience and a short update of diabetes mellitus occurrence [J]. Acta Biomed. 2022;93(4):e2022291.","journal-title":"Acta Biomed"},{"issue":"5","key":"5740_CR36","doi-asserted-by":"publisher","first-page":"103557","DOI":"10.1016\/j.transci.2022.103557","volume":"61","author":"ST ROLLINS M R, CHOU","year":"2022","unstructured":"ROLLINS M R, CHOU ST. Adverse events of red blood cell transfusions in patients with sickle cell disease [J]. Transfus Apheres Sci. 2022;61(5):103557.","journal-title":"Transfus Apheres Sci"},{"key":"5740_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.leukres.2018.09.005","volume":"74","author":"HA LEITCH","year":"2018","unstructured":"LEITCH HA, BUCKSTEIN R, ZHU N, et al. Iron overload in myelodysplastic syndromes: evidence based guidelines from the Canadian consortium on MDS [J]. Leuk Res. 2018;74:21\u201341.","journal-title":"Leuk Res"},{"issue":"11","key":"5740_CR38","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3390\/biom11111638","volume":"11","author":"D SCHIROLI","year":"2021","unstructured":"SCHIROLI D, MEROLLE L. Comparison of two alternative procedures to Obtain Packed Red Blood cells for \u03b2-Thalassemia major transfusion therapy [J]. Biomolecules. 2021;11(11):1638.","journal-title":"Biomolecules"},{"issue":"30","key":"5740_CR39","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","volume":"23","author":"L MALCOVATI","year":"2005","unstructured":"MALCOVATI L, PORTA M G D, PASCUTTO C, et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making [J]. J Clin Oncol. 2005;23(30):7594\u2013603.","journal-title":"J Clin Oncol"},{"issue":"1","key":"5740_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1053\/j.seminhematol.2011.10.003","volume":"49","author":"E BRISSOT","year":"2012","unstructured":"BRISSOT E, SAVANI B N MOHTYM. Management of high ferritin in Long-Term survivors after hematopoietic stem cell transplantation [J]. Semin Hematol. 2012;49(1):35\u201342.","journal-title":"Semin Hematol"},{"issue":"1","key":"5740_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2010.05544.x","volume":"1202","author":"HERSHKO C","year":"2010","unstructured":"HERSHKO C. Pathogenesis and management of iron toxicity in thalassemia [J]. Ann N Y Acad Sci. 2010;1202(1):1\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"5740_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jss.2020.05.015","volume":"255","author":"R HOGEN","year":"2020","unstructured":"HOGEN R, KIM M, LEE Y, et al. Liver transplantation in patients with Sickle Cell Disease in the United States [J]. J Surg Res. 2020;255:23\u201332.","journal-title":"J Surg Res"},{"key":"5740_CR43","doi-asserted-by":"publisher","first-page":"204062072311670","DOI":"10.1177\/20406207231167050","volume":"14","author":"M BU","year":"2023","unstructured":"BU M, DENG X, ZHANG Y, et al. Brain iron content and cognitive function in patients with \u03b2-thalassemia [J]. Therapeutic Adv Hematol. 2023;14:20406207231167050.","journal-title":"Therapeutic Adv Hematol"},{"key":"5740_CR44","doi-asserted-by":"crossref","unstructured":"GHIO AJ. Disruption of iron homeostasis and lung disease [J]. Biochimica et Biophysica Acta (BBA) - general subjects, 2009, 1790(7): 731\u20139.","DOI":"10.1016\/j.bbagen.2008.11.004"},{"issue":"5","key":"5740_CR45","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41574-023-00807-6","volume":"19","author":"L VALENTI","year":"2023","unstructured":"VALENTI L, CORRADINI E, ADAMS L A, et al. Consensus Statement on the definition and classification of metabolic hyperferritinaemia [J]. Nat Reviews Endocrinol. 2023;19(5):299\u2013310.","journal-title":"Nat Reviews Endocrinol"},{"issue":"10","key":"5740_CR46","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2174\/1381612826666200130090703","volume":"26","author":"A SACHINIDIS","year":"2020","unstructured":"SACHINIDIS A, DOUMAS M, IMPRIALOS K, et al. Dysmetabolic Iron overload in metabolic syndrome [J]. Curr Pharm Des. 2020;26(10):1019\u201324.","journal-title":"Curr Pharm Des"},{"key":"5740_CR47","doi-asserted-by":"publisher","first-page":"174613","DOI":"10.1016\/j.ejphar.2021.174613","volume":"912","author":"S LI","year":"2021","unstructured":"LI S, ZHANG H, CHANG J, et al. Iron overload and mitochondrial dysfunction orchestrate pulmonary fibrosis [J]. Eur J Pharmacol. 2021;912:174613.","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"5740_CR48","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1042\/CS20160072","volume":"130","author":"S CHIANG","year":"2016","unstructured":"CHIANG S, KOVACEVIC Z. Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich\u2019s ataxia [J]. Clin Sci (Lond). 2016;130(11):853\u201370.","journal-title":"Clin Sci (Lond)"},{"key":"5740_CR49","doi-asserted-by":"publisher","first-page":"1299201","DOI":"10.3389\/fmolb.2023.1299201","volume":"10","author":"SMITH F M","year":"2023","unstructured":"SMITH F M, KOSMAN D J. Loss of filamentous actin, tight junction protein expression, and paracellular barrier integrity in frataxin-deficient human brain microvascular endothelial cells-implications for blood-brain barrier physiology in Friedreich\u2019s ataxia [J]. Front Mol Biosci. 2023;10:1299201.","journal-title":"Front Mol Biosci"},{"issue":"2","key":"5740_CR50","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/JCI72931","volume":"124","author":"Y ICHIKAWA","year":"2014","unstructured":"ICHIKAWA Y, GHANEFAR M, BAYEVA M, et al. Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation [J]. J Clin Invest. 2014;124(2):617\u201330.","journal-title":"J Clin Invest"},{"issue":"7080","key":"5740_CR51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature04512","volume":"440","author":"L SHAW G C, COPE J J, LI","year":"2006","unstructured":"SHAW G C, COPE J J, LI L, et al. Mitoferrin is essential for erythroid iron assimilation [J]. Nature. 2006;440(7080):96\u2013100.","journal-title":"Nature"},{"issue":"9","key":"5740_CR52","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.biochi.2007.03.004","volume":"89","author":"M SATRE","year":"2007","unstructured":"SATRE M, MATTEI S. Mitochondrial carrier family: repertoire and peculiarities of the cellular slime mould Dictyostelium Discoideum [J]. Biochimie. 2007;89(9):1058\u201369.","journal-title":"Biochimie"},{"issue":"4","key":"5740_CR53","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1128\/MCB.01685-08","volume":"29","author":"PARADKAR P N","year":"2023","unstructured":"PARADKAR P N, ZUMBRENNEN K B, PAW B H, et al. Regulation of mitochondrial Iron import through Differential turnover of Mitoferrin 1 and mitoferrin 2 [J]. Mol Cell Biol. 2023;29(4):1007\u201316.","journal-title":"Mol Cell Biol"},{"issue":"20","key":"5740_CR54","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.1182\/blood-2010-11-319483","volume":"117","author":"WARNERD TROADEC M-B","year":"2011","unstructured":"TROADEC M-B WARNERD. Targeted deletion of the mouse Mitoferrin1 gene: from anemia to protoporphyria [J]. Blood. 2011;117(20):5494\u2013502.","journal-title":"Blood"},{"issue":"1","key":"5740_CR55","doi-asserted-by":"publisher","first-page":"112552","DOI":"10.1016\/j.yexcr.2021.112552","volume":"402","author":"D WANG","year":"2021","unstructured":"WANG D, YE P, KONG C, et al. Mitoferrin 2 deficiency prevents mitochondrial iron overload-induced endothelial injury and alleviates atherosclerosis [J]. Exp Cell Res. 2021;402(1):112552.","journal-title":"Exp Cell Res"},{"issue":"8","key":"5740_CR56","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nchembio807","volume":"2","author":"ROUAULT T A","year":"2006","unstructured":"ROUAULT T A. The role of iron regulatory proteins in mammalian iron homeostasis and disease [J]. Nat Chem Biol. 2006;2(8):406\u201314.","journal-title":"Nat Chem Biol"},{"issue":"4","key":"5740_CR57","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00109-009-0565-x","volume":"88","author":"M RICHARDSON D R, HUANG M L H, WHITNA","year":"2009","unstructured":"RICHARDSON D R, HUANG M L H, WHITNALL M, et al. The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich\u2019s ataxia [J]. J Mol Med. 2009;88(4):323\u20139.","journal-title":"J Mol Med"},{"key":"5740_CR58","doi-asserted-by":"crossref","unstructured":"MITCHELL P. Coupling of phosphorylation to Electron and Hydrogen Transfer by a Chemi-osmotic type of mechanism [J]. Nature, 1961, 191(4784): 144\u20138.","DOI":"10.1038\/191144a0"},{"issue":"1","key":"5740_CR59","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s44324-024-00008-3","volume":"2","author":"E MARQUES","year":"2024","unstructured":"MARQUES E, KRAMER R, RYAN DG. Multifaceted mitochondria in innate immunity [J]. NPJ Metab Health Dis. 2024;2(1):6.","journal-title":"NPJ Metab Health Dis"},{"key":"5740_CR60","doi-asserted-by":"crossref","unstructured":"KRUSZEWSKI M. Labile iron pool: the main determinant of cellular response to oxidative stress [J]. Mutat Research\/Fundamental Mol Mech Mutagen, 2003, 531(1\u20132): 81\u201392.","DOI":"10.1016\/j.mrfmmm.2003.08.004"},{"issue":"11","key":"5740_CR61","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.3390\/diagnostics12112817","volume":"12","author":"K M\u0141ODZI\u0143SKI","year":"2022","unstructured":"M\u0141ODZI\u0143SKI K, \u015aWI\u0104TCZAK M, ROHUN J, et al. Vascular aging and damage in patients with Iron Metabolism disorders [J]. Diagnostics. 2022;12(11):2817.","journal-title":"Diagnostics"},{"key":"5740_CR62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cca.2022.04.004","volume":"531","author":"B ANGORO","year":"2022","unstructured":"ANGORO B, MOTSHAKERI M, HEMMAWAY C, et al. Non-transferrin bound iron [J]. Clin Chim Acta. 2022;531:157\u201367.","journal-title":"Clin Chim Acta"},{"issue":"10","key":"5740_CR63","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nrm2256","volume":"8","author":"B D\u2019AUTR\u00e9AUX","year":"2007","unstructured":"D\u2019AUTR\u00e9AUX B. TOLEDANO M B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis [J]. Nat Rev Mol Cell Biol. 2007;8(10):813\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"5740_CR64","first-page":"1","volume":"417","author":"MURPHY MICHAEL P","year":"2008","unstructured":"MURPHY MICHAEL P. How mitochondria produce reactive oxygen species [J]. Biochem J. 2008;417(1):1\u201313.","journal-title":"Biochem J"},{"issue":"10","key":"5740_CR65","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1134\/S0006297916100059","volume":"81","author":"J STIBAN","year":"2016","unstructured":"STIBAN J, SO M, KAGUNI LS. Iron-sulfur clusters in mitochondrial metabolism: multifaceted roles of a simple cofactor [J]. Biochem (Moscow). 2016;81(10):1066\u201380.","journal-title":"Biochem (Moscow)"},{"issue":"2","key":"5740_CR66","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bcmd.2013.04.002","volume":"51","author":"A FILOSA","year":"2013","unstructured":"FILOSA A, VITRANO A, RIGANO P, et al. Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with Thalassemia major [J]. Blood Cells Molecules Dis. 2013;51(2):85\u20138.","journal-title":"Blood Cells Molecules Dis"},{"issue":"1","key":"5740_CR67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1532-429X-13-45","volume":"13","author":"M PENNELL D J, CARPENTER J P, ROUGHTO","year":"2011","unstructured":"PENNELL D J, CARPENTER J P, ROUGHTON M, et al. On improvement in ejection fraction with iron chelation in Thalassemia major and the risk of future heart failure [J]. J Cardiovasc Magn Reson. 2011;13(1):45.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"8","key":"5740_CR68","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1002\/jcp.31044","volume":"238","author":"E TAM","year":"2023","unstructured":"TAM E, SUNG H K SWEENEYG. MitoNEET prevents iron overload-induced insulin resistance in H9c2 cells through regulation of mitochondrial iron [J]. J Cell Physiol. 2023;238(8):1867\u201375.","journal-title":"J Cell Physiol"},{"key":"5740_CR69","doi-asserted-by":"crossref","unstructured":"PADDOCK M L, WILEY S E, AXELROD H L et al. MitoNEET is a uniquely folded 2Fe\u20132S outer mitochondrial membrane protein stabilized by pioglitazone [J]. Proceedings of the National Academy of Sciences, 2007, 104(36): 14342-7.","DOI":"10.1073\/pnas.0707189104"},{"issue":"2","key":"5740_CR70","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12011-019-01733-3","volume":"193","author":"C CAVDAR Z, OKTAN M A, URAL","year":"2019","unstructured":"CAVDAR Z, OKTAN M A, URAL C, et al. Renoprotective effects of Alpha Lipoic Acid on Iron Overload-Induced kidney Injury in rats by suppressing NADPH oxidase 4 and p38 MAPK signaling [J]. Biol Trace Elem Res. 2019;193(2):483\u201393.","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"5740_CR71","doi-asserted-by":"publisher","first-page":"19773","DOI":"10.1038\/s41598-023-47127-3","volume":"13","author":"M SADEK S A, MARZOUK","year":"2023","unstructured":"SADEK S A, MARZOUK M, MOHAMED H R H, et al. Chia seeds and coenzyme Q10 alleviate iron overload induced hepatorenal toxicity in mice via iron chelation and oxidative stress modulation [J]. Sci Rep. 2023;13(1):19773.","journal-title":"Sci Rep"},{"key":"5740_CR72","doi-asserted-by":"publisher","first-page":"101426","DOI":"10.1016\/j.redox.2020.101426","volume":"33","author":"C LARSON-CASEY J L, HE","year":"2020","unstructured":"LARSON-CASEY J L, HE C. CARTER A B. mitochondrial quality control in pulmonary fibrosis [J]. Redox Biol. 2020;33:101426.","journal-title":"Redox Biol"},{"issue":"9","key":"5740_CR73","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1182\/blood-2006-05-020867","volume":"108","author":"H GLICKSTEIN","year":"2006","unstructured":"GLICKSTEIN H, EL R B, LINK G, et al. Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences [J]. Blood. 2006;108(9):3195\u2013203.","journal-title":"Blood"},{"key":"5740_CR74","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-024-02022-5","author":"X WANG","year":"2024","unstructured":"WANG X, WEI T, LUO J, et al. Iron overload\u2013dependent ferroptosis aggravates LPS-Induced Acute Lung Injury by impairing mitochondrial function [J]. Inflammation. 2024. https:\/\/doi.org\/10.1007\/s10753-024-02022-5.","journal-title":"Inflammation"},{"issue":"2","key":"5740_CR75","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10534-022-00383-8","volume":"36","author":"A CILIBRIZZI","year":"2022","unstructured":"CILIBRIZZI A, POURZAND C. The synthesis and properties of mitochondrial targeted iron chelators [J]. Biometals. 2022;36(2):321\u201337.","journal-title":"Biometals"},{"issue":"6","key":"5740_CR76","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s10534-012-9579-x","volume":"25","author":"S KUMFU","year":"2012","unstructured":"KUMFU S, CHATTIPAKORN S, FUCHAROEN S, et al. Mitochondrial calcium uniporter blocker prevents cardiac mitochondrial dysfunction induced by iron overload in thalassemic mice [J]. Biometals. 2012;25(6):1167\u201375.","journal-title":"Biometals"},{"issue":"2","key":"5740_CR77","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/apha.12162","volume":"210","author":"J SRIPETCHWANDEE","year":"2014","unstructured":"SRIPETCHWANDEE J, KENKNIGHT S B, SANIT J, et al. Blockade of mitochondrial calcium uniporter prevents cardiac mitochondrial dysfunction caused by iron overload [J]. Acta Physiologica (Oxford England). 2014;210(2):330\u201341.","journal-title":"Acta Physiologica (Oxford England)"},{"issue":"2","key":"5740_CR78","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4110\/in.2017.17.2.77","volume":"17","author":"HS JIN","year":"2017","unstructured":"JIN HS, SUH H-W, KIM S-J, et al. Mitochondrial Control of Innate Immunity and Inflammation [J]. Immune Netw. 2017;17(2):77\u201388.","journal-title":"Immune Netw"},{"issue":"4","key":"5740_CR79","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1152\/physrev.00058.2021","volume":"103","author":"J HARRINGTON","year":"2023","unstructured":"HARRINGTON J, RYTER S, PLATAKI M, et al. Mitochondria in health, disease, and aging [J]. Physiol Rev. 2023;103(4):2349\u2013422.","journal-title":"Physiol Rev"},{"issue":"2","key":"5740_CR80","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41418-022-01094-w","volume":"30","author":"G VRINGER E, TAIT S W","year":"2023","unstructured":"VRINGER E, TAIT S W G. Mitochondria and cell death-associated inflammation [J]. Cell Death Differ. 2023;30(2):304\u201312.","journal-title":"Cell Death Differ"},{"issue":"0","key":"5740_CR81","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jot.2024.03.005","volume":"46","author":"X JING","year":"2024","unstructured":"JING X, WANG W, HE X, et al. HIF-2\u03b1\/TFR1 mediated iron homeostasis disruption aggravates cartilage endplate degeneration through ferroptotic damage and mtDNA release: a new mechanism of intervertebral disc degeneration [J]. J Orthop Translation. 2024;46(0):65\u201378.","journal-title":"J Orthop Translation"},{"issue":"3","key":"5740_CR82","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.freeradbiomed.2010.04.033","volume":"49","author":"X GAO","year":"2010","unstructured":"GAO X, QIAN M. Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload [J]. Free Radic Biol Med. 2010;49(3):401\u20137.","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"5740_CR83","doi-asserted-by":"publisher","first-page":"e88150","DOI":"10.1172\/jci.insight.88150","volume":"1","author":"A LAL","year":"2016","unstructured":"LAL A, GOMEZ E. Increased mitochondrial DNA deletions and copy number in transfusion-dependent thalassemia [J]. JCI Insight. 2016;1(12):e88150.","journal-title":"JCI Insight"},{"issue":"8","key":"5740_CR84","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1007\/s12011-021-02981-y","volume":"200","author":"MOHAMED H R H","year":"2021","unstructured":"MOHAMED H R H. Alleviation of Cadmium Chloride\u2013Induced Acute Genotoxicity, mitochondrial DNA disruption, and ROS Generation by Chocolate Coadministration in mice liver and kidney tissues [J]. Biol Trace Elem Res. 2021;200(8):3750\u201361.","journal-title":"Biol Trace Elem Res"},{"issue":"15","key":"5740_CR85","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1182\/blood.2020006987","volume":"137","author":"F PETIT","year":"2021","unstructured":"PETIT F, DRECOURT A, DUSSIOT M, et al. Defective palmitoylation of transferrin receptor triggers iron overload in Friedreich ataxia fibroblasts [J]. Blood. 2021;137(15):2090\u2013102.","journal-title":"Blood"},{"issue":"8","key":"5740_CR86","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1074\/jbc.M806235200","volume":"284","author":"X GAO","year":"2009","unstructured":"GAO X, CAMPIAN J L, QIAN M, et al. Mitochondrial DNA damage in Iron overload [J]. J Biol Chem. 2009;284(8):4767\u201375.","journal-title":"J Biol Chem"},{"issue":"4","key":"5740_CR87","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3892\/mmr.2013.1316","volume":"7","author":"H LIU D A N, HE","year":"2013","unstructured":"LIU D A N, HE H, YIN D, et al. Mechanism of chronic dietary iron overload-induced liver damage in mice [J]. Mol Med Rep. 2013;7(4):1173\u20139.","journal-title":"Mol Med Rep"},{"key":"5740_CR88","doi-asserted-by":"crossref","unstructured":"BRADY N R, HAMACHER-BRADY A, WESTERHOFF H V, et al. A Wave of reactive oxygen species (ROS)-Induced ROS Release in a sea of Excitable Mitochondria [J]. Volume 8. Antioxidants & Redox Signaling; 2006. pp. 1651\u201365. 9\u201310.","DOI":"10.1089\/ars.2006.8.1651"},{"issue":"8","key":"5740_CR89","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3390\/antiox9080758","volume":"9","author":"R GORDAN","year":"2020","unstructured":"GORDAN R, FEFELOVA N GWATHMEYJK, et al. Iron overload, oxidative stress and calcium mishandling in Cardiomyocytes: role of the mitochondrial permeability transition pore [J]. Antioxidants. 2020;9(8):758.","journal-title":"Antioxidants"},{"key":"5740_CR90","doi-asserted-by":"crossref","unstructured":"KASHYAP D, GARG V. GOEL N. Intrinsic and extrinsic pathways of apoptosis: role in cancer development and prognosis [J]. Advances in protein chemistry and structural biology, 2021, 125: 73\u2013120.","DOI":"10.1016\/bs.apcsb.2021.01.003"},{"issue":"10","key":"5740_CR91","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s13238-014-0089-1","volume":"5","author":"S XIONG","year":"2014","unstructured":"XIONG S, MU T, WANG G, et al. Mitochondria-mediated apoptosis in mammals [J]. Protein Cell. 2014;5(10):737\u201349.","journal-title":"Protein Cell"},{"issue":"2","key":"5740_CR92","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41418-022-01094-w","volume":"30","author":"G VRINGER E, TAIT S W","year":"2022","unstructured":"VRINGER E, TAIT S W G. Mitochondria and cell death-associated inflammation [J]. Cell Death Differ. 2022;30(2):304\u201312.","journal-title":"Cell Death Differ"},{"issue":"3","key":"5740_CR93","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R SINGH","year":"2019","unstructured":"SINGH R, LETAI A, SAROSIEK K. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins [J]. Nat Rev Mol Cell Biol. 2019;20(3):175\u201393.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"5740_CR94","first-page":"1192","volume":"143","author":"MJ VERBRUGGE I, JOHNSTONE R W, SMYTH","year":"2010","unstructured":"VERBRUGGE I, JOHNSTONE R W, SMYTH MJ, SnapShot. Extrinsic Apoptosis Pathways [J] Cell. 2010;143(7):1192\u2013e2.","journal-title":"Extrinsic Apoptosis Pathways [J] Cell"},{"issue":"11","key":"5740_CR95","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41580-018-0052-8","volume":"19","author":"C GIORGI","year":"2018","unstructured":"GIORGI C, MARCHI S. The machineries, regulation and cellular functions of mitochondrial calcium [J]. Nat Rev Mol Cell Biol. 2018;19(11):713\u201330.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"5740_CR96","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/biom10070998","volume":"10","author":"M BONORA","year":"2020","unstructured":"BONORA M, PATERGNANI S, RAMACCINI D, et al. Physiopathology of the permeability transition pore: Molecular mechanisms in Human Pathology [J]. Biomolecules. 2020;10(7):998.","journal-title":"Biomolecules"},{"key":"5740_CR97","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2022.12.105","volume":"196","author":"Y WU","year":"2023","unstructured":"WU Y, YANG R, LAN J, et al. Iron overload modulates follicular microenvironment via ROS\/HIF-1\u03b1\/FSHR signaling [J]. Free Radic Biol Med. 2023;196:37\u201352.","journal-title":"Free Radic Biol Med"},{"key":"5740_CR98","doi-asserted-by":"publisher","first-page":"109954","DOI":"10.1016\/j.abb.2024.109954","volume":"754","author":"W WUDHIKULPRAPAN","year":"2024","unstructured":"WUDHIKULPRAPAN W, CHATTIPAKORN S C, CHATTIPAKORN N, et al. Iron overload and programmed bone marrow cell death: potential mechanistic insights [J]. Arch Biochem Biophys. 2024;754:109954.","journal-title":"Arch Biochem Biophys"},{"key":"5740_CR99","doi-asserted-by":"crossref","unstructured":"ZHOU S, SUN L, QIAN S, et al. Iron overload adversely effects bone marrow haematogenesis via SIRT-SOD2-mROS in a process ameliorated by curcumin [J]. Volume 26. Cellular & Molecular Biology Letters; 2021. p. 2. 1.","DOI":"10.1186\/s11658-020-00244-7"},{"key":"5740_CR100","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","volume":"4","author":"BM PITTENGER M F, DISCHER D E, P\u00e9AULT","year":"2019","unstructured":"PITTENGER M F, DISCHER D E, P\u00e9AULT BM, et al. Mesenchymal stem cell perspective: cell biology to clinical progress [J]. NPJ Regen Med. 2019;4:22.","journal-title":"NPJ Regen Med"},{"issue":"10","key":"5740_CR101","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.3324\/haematol.2018.193128","volume":"103","author":"X JIN","year":"2018","unstructured":"JIN X, HE X, CAO X, et al. Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice [J]. Haematologica. 2018;103(10):1627\u201334.","journal-title":"Haematologica"},{"issue":"1","key":"5740_CR102","doi-asserted-by":"publisher","first-page":"41900","DOI":"10.1038\/srep41900","volume":"7","author":"X CHAI","year":"2017","unstructured":"CHAI X, LI D, CAO X, et al. Correction: Corrigendum: ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem\/progenitor cells in mice [J]. Sci Rep. 2017;7(1):41900.","journal-title":"Sci Rep"},{"key":"5740_CR103","doi-asserted-by":"publisher","first-page":"110024","DOI":"10.1016\/j.cellsig.2021.110024","volume":"84","author":"J CHE","year":"2021","unstructured":"CHE J, LV H, YANG J, et al. Iron overload induces apoptosis of osteoblast cells via eliciting ER stress-mediated mitochondrial dysfunction and p-eIF2\u03b1\/ATF4\/CHOP pathway in vitro [J]. Cell Signal. 2021;84:110024.","journal-title":"Cell Signal"},{"issue":"5","key":"5740_CR104","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"DIXON SCOTT J","year":"2012","unstructured":"DIXON SCOTT J, LEMBERG KATHRYN M, LAMPRECHT MICHAEL R, et al. Ferroptosis: An Iron-Dependent form of nonapoptotic cell death [J]. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"issue":"12","key":"5740_CR105","first-page":"1864","volume":"10","author":"D MANCARDI","year":"2021","unstructured":"MANCARDI D, MEZZANOTTE M. Iron overload, oxidative stress, and ferroptosis in the failing heart and liver [J]. Antioxid (Basel Switzerland). 2021;10(12):1864.","journal-title":"Antioxid (Basel Switzerland)"},{"issue":"6","key":"5740_CR106","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1182\/blood.2020008455","volume":"139","author":"J MENON A V, LIU","year":"2022","unstructured":"MENON A V, LIU J, TSAI H P, et al. Excess heme upregulates heme oxygenase 1 and promotes cardiac ferroptosis in mice with sickle cell disease [J]. Blood. 2022;139(6):936\u201341.","journal-title":"Blood"},{"key":"5740_CR107","doi-asserted-by":"crossref","unstructured":"FANG X, WANG H et al. HAN D,. Ferroptosis as a target for protection against cardiomyopathy [J]. Proceedings of the National Academy of Sciences, 2019, 116(7): 2672-80.","DOI":"10.1073\/pnas.1821022116"},{"issue":"7360","key":"5740_CR108","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature10230","volume":"476","author":"A DE STEFANI D, RAFFAELLO","year":"2011","unstructured":"DE STEFANI D, RAFFAELLO A. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter [J]. Nature. 2011;476(7360):336\u201340.","journal-title":"Nature"},{"issue":"3","key":"5740_CR109","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s11427-022-2244-4","volume":"66","author":"Y LI","year":"2022","unstructured":"LI Y, OUYANG Q, CHEN W, et al. An iron-dependent form of non-canonical ferroptosis induced by labile iron [J]. Sci China Life Sci. 2022;66(3):516\u201327.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"5740_CR110","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"ZOUT YAN H-F","year":"2021","unstructured":"YAN H-F ZOUT, TUO Q-Z, et al. Ferroptosis: mechanisms and links with diseases [J]. Signal Transduct Target Therapy. 2021;6(1):49.","journal-title":"Signal Transduct Target Therapy"},{"issue":"3","key":"5740_CR111","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/nu15030591","volume":"15","author":"Y CHEN","year":"2023","unstructured":"CHEN Y, LI X, WANG S, et al. Targeting Iron Metabolism and Ferroptosis as Novel Therapeutic approaches in Cardiovascular diseases [J]. Nutrients. 2023;15(3):591.","journal-title":"Nutrients"},{"issue":"14","key":"5740_CR112","doi-asserted-by":"publisher","first-page":"4300","DOI":"10.3390\/molecules26144300","volume":"26","author":"L YANG","year":"2021","unstructured":"YANG L, LIU Y, ZHANG W, et al. Ferroptosis-inhibitory difference between Chebulagic Acid and Chebulinic Acid indicates beneficial role of HHDP [J]. Molecules. 2021;26(14):4300.","journal-title":"Molecules"},{"issue":"9374","key":"5740_CR113","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/S0140-6736(03)13637-9","volume":"361","author":"VIVEKANANTHAN D P","year":"2003","unstructured":"VIVEKANANTHAN D P, PENN M S, SAPP S K, et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials [J]. Lancet. 2003;361(9374):2017\u201323.","journal-title":"Lancet"},{"issue":"8","key":"5740_CR114","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1001\/jama.297.8.842","volume":"297","author":"G BJELAKOVIC","year":"2007","unstructured":"BJELAKOVIC G, NIKOLOVA D. Mortality in Randomized trials of antioxidant supplements for primary and secondary Prevention [J]. JAMA. 2007;297(8):842\u201357.","journal-title":"JAMA"},{"issue":"0","key":"5740_CR115","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bbrc.2021.05.011","volume":"561","author":"G SU","year":"2021","unstructured":"SU G, YANG W, WANG S, et al. SIRT1-autophagy axis inhibits excess iron-induced ferroptosis of foam cells and subsequently increases IL-1\u0392 and IL-18 [J]. Biochem Biophys Res Commun. 2021;561(0):33\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"5740_CR116","doi-asserted-by":"publisher","first-page":"101912","DOI":"10.1016\/j.redox.2021.101912","volume":"41","author":"Q LUO","year":"2021","unstructured":"LUO Q, SONG Y, KANG J, et al. RETRACTED: mtROS-mediated Akt\/AMPK\/mTOR pathway was involved in copper-induced autophagy and it attenuates copper-induced apoptosis in RAW264.7 mouse monocytes [J]. Redox Biol. 2021;41:101912.","journal-title":"Redox Biol"},{"issue":"0","key":"5740_CR117","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.redox.2015.09.005","volume":"6","author":"X DAN DUNN J, ALVAREZ L A J, ZHANG","year":"2015","unstructured":"DAN DUNN J, ALVAREZ L A J, ZHANG X, et al. Reactive oxygen species and mitochondria: a nexus of cellular homeostasis [J]. Redox Biol. 2015;6(0):472\u201385.","journal-title":"Redox Biol"},{"key":"5740_CR118","doi-asserted-by":"crossref","unstructured":"SUNG H K, MURUGATHASAN M, ABDUL-SATER A A, et al. Autophagy deficiency exacerbates iron overload induced reactive oxygen species production and apoptotic cell death in skeletal muscle cells [J]. Volume 14. Cell Death & Disease; 2023. p. 252. 4.","DOI":"10.1038\/s41419-022-05484-3"},{"issue":"1","key":"5740_CR119","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1478-3231.2008.01793.x","volume":"29","author":"G MESSNER D J, SIVAM","year":"2008","unstructured":"MESSNER D J, SIVAM G. KOWDLEY K V. Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells [J]. Liver Int. 2008;29(1):63\u201372.","journal-title":"Liver Int"},{"issue":"4","key":"5740_CR120","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41418-017-0017-z","volume":"25","author":"LM LINDQVIST","year":"2017","unstructured":"LINDQVIST LM, FRANK D, MCARTHUR K, et al. Autophagy induced during apoptosis degrades mitochondria and inhibits type I interferon secretion [J]. Cell Death Differ. 2017;25(4):784\u201396.","journal-title":"Cell Death Differ"},{"issue":"13","key":"5740_CR121","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.15252\/embj.201796697","volume":"36","author":"L GALLUZZI","year":"2017","unstructured":"GALLUZZI L, BAEHRECKE E H, BALLABIO A, et al. Molecular definitions of autophagy and related processes [J]. EMBO J. 2017;36(13):1811\u201336.","journal-title":"EMBO J"},{"issue":"18","key":"5740_CR122","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1113\/JP272703","volume":"594","author":"S CADETE V J J, DESCH\u00eaNES","year":"2016","unstructured":"CADETE V J J, DESCH\u00eaNES S, CUILLERIER A, et al. Formation of mitochondrial-derived vesicles is an active and physiologically relevant mitochondrial quality control process in the cardiac system [J]. J Physiol. 2016;594(18):5343\u201362.","journal-title":"J Physiol"},{"issue":"3","key":"5740_CR123","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41577-022-00760-x","volume":"23","author":"S MARCHI","year":"2022","unstructured":"MARCHI S, GUILBAUD E, TAIT S W, G, et al. Mitochondrial control of inflammation [J]. Nat Rev Immunol. 2022;23(3):159\u201373.","journal-title":"Nat Rev Immunol"},{"key":"5740_CR124","doi-asserted-by":"crossref","unstructured":"LEE JM, HWANG J W, KIM M J et al. Mitochondrial Transplantation Modulates Inflammation and Apoptosis, Alleviating Tendinopathy Both In Vivo and In Vitro [J]. Antioxidants, 2021, 10(5): 696.","DOI":"10.3390\/antiox10050696"},{"issue":"2","key":"5740_CR125","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tem.2015.12.001","volume":"27","author":"T WAI","year":"2016","unstructured":"WAI T. Mitochondrial dynamics and metabolic regulation [J]. Trends Endocrinol Metabolism. 2016;27(2):105\u201317.","journal-title":"Trends Endocrinol Metabolism"},{"key":"5740_CR126","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejphar.2017.02.015","volume":"799","author":"J KHAMSEEKAEW","year":"2017","unstructured":"KHAMSEEKAEW J, KUMFU S. Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice [J]. Eur J Pharmacol. 2017;799:118\u201327.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"5740_CR127","doi-asserted-by":"publisher","first-page":"7743","DOI":"10.1074\/jbc.C200677200","volume":"278","author":"A OLICHON","year":"2003","unstructured":"OLICHON A, BARICAULT L, GAS N, et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and Integrity, leading to cytochrome c release and apoptosis [J]. J Biol Chem. 2003;278(10):7743\u20136.","journal-title":"J Biol Chem"},{"key":"5740_CR128","doi-asserted-by":"crossref","unstructured":"YU T, ROBOTHAM J L, YOON Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology [J]. Proceedings of the National Academy of Sciences, 2006, 103(8): 2653-8.","DOI":"10.1073\/pnas.0511154103"},{"key":"5740_CR129","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fnmol.2018.00003","volume":"11","author":"A RUIZ","year":"2018","unstructured":"RUIZ A, ALBERDI E. Mitochondrial division inhibitor 1 (mdivi-1) protects neurons against excitotoxicity through the modulation of mitochondrial function and intracellular Ca2\u2009+\u2009signaling [J]. Front Mol Neurosci. 2018;11:3.","journal-title":"Front Mol Neurosci"},{"key":"5740_CR130","doi-asserted-by":"crossref","unstructured":"ZHENG Q, ZHAO Y, GUO J, et al. Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK\/MFF\/Drp1 pathway [J]. Volume 9. Cell Death & Disease; 2018. p. 515. 5.","DOI":"10.1038\/s41419-018-0552-7"},{"issue":"9","key":"5740_CR131","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.7150\/ijbs.83348","volume":"19","author":"J LI","year":"2023","unstructured":"LI J, JIA Y-C, DING Y-X, et al. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks [J]. Int J Biol Sci. 2023;19(9):2756\u201371.","journal-title":"Int J Biol Sci"},{"key":"5740_CR132","doi-asserted-by":"publisher","first-page":"102871","DOI":"10.1016\/j.redox.2023.102871","volume":"67","author":"S YAO","year":"2023","unstructured":"YAO S, PANG M, WANG Y, et al. Mesenchymal stem cell attenuates spinal cord injury by inhibiting mitochondrial quality control-associated neuronal ferroptosis [J]. Redox Biol. 2023;67:102871.","journal-title":"Redox Biol"},{"key":"5740_CR133","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2018.10.413","volume":"133","author":"MD KNUTSON","year":"2019","unstructured":"KNUTSON MD. Non-transferrin-bound iron transporters [J]. Free Radic Biol Med. 2019;133:101\u201311.","journal-title":"Free Radic Biol Med"},{"key":"5740_CR134","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biocel.2018.06.005","volume":"102","author":"LEE D G","year":"2018","unstructured":"LEE D G, KAM M K, KIM K M, et al. Peroxiredoxin 5 prevents iron overload-induced neuronal death by inhibiting mitochondrial fragmentation and endoplasmic reticulum stress in mouse hippocampal HT-22 cells [J]. Int J Biochem Cell Biol. 2018;102:10\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"5740_CR135","doi-asserted-by":"publisher","first-page":"e13428","DOI":"10.1111\/apha.13428","volume":"229","author":"M DING","year":"2020","unstructured":"DING M, LIU C, SHI R, et al. Mitochondrial fusion promoter restores mitochondrial dynamics balance and ameliorates diabetic cardiomyopathy in an optic atrophy 1-dependent way [J]. Acta Physiol. 2020;229(1):e13428.","journal-title":"Acta Physiol"},{"issue":"1","key":"5740_CR136","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41401-021-00626-3","volume":"43","author":"C MANEECHOTE","year":"2021","unstructured":"MANEECHOTE C, PALEE S. Modulating mitochondrial dynamics attenuates cardiac ischemia-reperfusion injury in prediabetic rats [J]. Acta Pharmacol Sin. 2021;43(1):26\u201338.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"5740_CR137","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-024-01839-8","volume":"9","author":"Y ZONG","year":"2024","unstructured":"ZONG Y, LI H, LIAO P, et al. Mitochondrial dysfunction: mechanisms and advances in therapy [J]. Signal Transduct Target Ther. 2024;9(1):124.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"5740_CR138","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.3390\/ijms22094793","volume":"22","author":"A PARK","year":"2021","unstructured":"PARK A, OH M. Mitochondrial transplantation as a Novel Therapeutic Strategy for mitochondrial diseases [J]. Int J Mol Sci. 2021;22(9):4793.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5740_CR139","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12967-021-02878-3","volume":"19","author":"K HAYASHIDA","year":"2021","unstructured":"HAYASHIDA K, TAKEGAWA R, SHOAIB M, et al. Mitochondrial transplantation therapy for ischemia reperfusion injury: a systematic review of animal and human studies [J]. J Translational Med. 2021;19(1):214.","journal-title":"J Translational Med"},{"issue":"6","key":"5740_CR140","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.7150\/thno.69533","volume":"12","author":"L XIA","year":"2022","unstructured":"XIA L, ZHANG C, LV N, et al. AdMSC-derived exosomes alleviate acute lung injury via transferring mitochondrial component to improve homeostasis of alveolar macrophages [J]. Theranostics. 2022;12(6):2928\u201347.","journal-title":"Theranostics"},{"issue":"0","key":"5740_CR141","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mito.2022.04.004","volume":"65","author":"W ZHOU","year":"2022","unstructured":"ZHOU W, ZHAO Z, YU Z, et al. Mitochondrial transplantation therapy inhibits the proliferation of malignant hepatocellular carcinoma and its mechanism [J]. Mitochondrion. 2022;65(0):11\u201322.","journal-title":"Mitochondrion"},{"issue":"8","key":"5740_CR142","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.7150\/ijbs.59581","volume":"17","author":"Z YU","year":"2021","unstructured":"YU Z, HOU Y, ZHOU W, et al. The effect of mitochondrial transplantation therapy from different gender on inhibiting cell proliferation of malignant melanoma [J]. Int J Biol Sci. 2021;17(8):2021\u201333.","journal-title":"Int J Biol Sci"},{"key":"5740_CR143","doi-asserted-by":"publisher","first-page":"963689721102421","DOI":"10.1177\/09636897211024210","volume":"30","author":"C SHI","year":"2021","unstructured":"SHI C, GUO H. Platelet Mitochondria Transplantation rescues Hypoxia\/Reoxygenation-Induced mitochondrial dysfunction and neuronal cell death involving the FUNDC2\/PIP3\/Akt\/FOXO3a Axis [J]. Cell Transplant. 2021;30:9636897211024210.","journal-title":"Cell Transplant"},{"issue":"6","key":"5740_CR144","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1016\/j.apsb.2022.03.001","volume":"12","author":"J XU","year":"2022","unstructured":"XU J, DU W, ZHAO Y, et al. Mitochondria targeting drugs for neurodegenerative diseases\u2014Design, mechanism and application [J]. Acta Pharm Sinica B. 2022;12(6):2778\u201389.","journal-title":"Acta Pharm Sinica B"},{"key":"5740_CR145","doi-asserted-by":"crossref","unstructured":"CHEN P, YAO L, YUAN M, et al. Mitochondrial dysfunction: a promising therapeutic target for liver diseases [J]. Volume 11. Genes & Diseases; 2024. p. 101115. 3.","DOI":"10.1016\/j.gendis.2023.101115"},{"issue":"0","key":"5740_CR146","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jconrel.2021.06.024","volume":"336","author":"Y HUANG","year":"2021","unstructured":"HUANG Y, MA M, ZHU X, et al. Effectiveness of idebenone nanorod formulations in the treatment of Alzheimer\u2019s disease [J]. J Controlled Release. 2021;336(0):169\u201380.","journal-title":"J Controlled Release"},{"issue":"1","key":"5740_CR147","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.1038\/s41598-018-24900-3","volume":"8","author":"J BEYRATH","year":"2018","unstructured":"BEYRATH J, PELLEGRINI M, RENKEMA H, et al. KH176 safeguards mitochondrial diseased cells from Redox stress-Induced cell death by interacting with the Thioredoxin System\/Peroxiredoxin Enzyme Machinery [J]. Sci Rep. 2018;8(1):6577.","journal-title":"Sci Rep"},{"issue":"2","key":"5740_CR148","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ymgme.2013.03.011","volume":"109","author":"A PASTORE","year":"2013","unstructured":"PASTORE A, PETRILLO S, TOZZI G, et al. Glutathione: a redox signature in monitoring EPI-743 therapy in children with mitochondrial encephalomyopathies [J]. Mol Genet Metab. 2013;109(2):208\u201314.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"5740_CR149","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","volume":"21","author":"G BOCK F J, TAIT S W","year":"2019","unstructured":"BOCK F J, TAIT S W G. Mitochondria as multifaceted regulators of cell death [J]. Nat Rev Mol Cell Biol. 2019;21(2):85\u2013100.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"5740_CR150","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tips.2018.11.004","volume":"40","author":"T BRISTON","year":"2019","unstructured":"BRISTON T, SELWOOD D L, SZABADKAI G, et al. Mitochondrial permeability transition: a molecular lesion with multiple drug targets [J]. Trends Pharmacol Sci. 2019;40(1):50\u201370.","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"5740_CR151","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s10495-014-1051-7","volume":"20","author":"M KVANSAKUL","year":"2014","unstructured":"KVANSAKUL M, HINDS MG. The Bcl-2 family: structures, interactions and targets for drug discovery [J]. Apoptosis. 2014;20(2):136\u201350.","journal-title":"Apoptosis"},{"issue":"14","key":"5740_CR152","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1080\/15384101.2022.2054096","volume":"21","author":"ML WINDER","year":"2022","unstructured":"WINDER ML, CAMPBELL K J. MCL-1 is a clinically targetable vulnerability in breast cancer [J]. Cell Cycle. 2022;21(14):1439\u201355.","journal-title":"Cell Cycle"},{"key":"5740_CR153","doi-asserted-by":"crossref","unstructured":"SMITH R A J, PORTEOUS C M, GANE A M et al. Delivery of bioactive molecules to mitochondria in vivo [J]. Proceedings of the National Academy of Sciences, 2003, 100(9): 5407-12.","DOI":"10.1073\/pnas.0931245100"},{"issue":"7\u20138","key":"5740_CR154","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.bbabio.2008.03.029","volume":"1777","author":"MURPHY M P","year":"2008","unstructured":"MURPHY M P. Targeting lipophilic cations to mitochondria [J]. Biochimica et Biophysica Acta (BBA). - Bioenergetics. 2008;1777(7\u20138):1028\u201331.","journal-title":"- Bioenergetics"},{"issue":"2","key":"5740_CR155","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1161\/HYPERTENSIONAHA.109.130351","volume":"54","author":"D GRAHAM","year":"2009","unstructured":"GRAHAM D, HUYNH N N HAMILTONCA, et al. Mitochondria-targeted antioxidant MitoQ 10 improves endothelial function and attenuates cardiac hypertrophy [J]. Hypertension. 2009;54(2):322\u20138.","journal-title":"Hypertension"},{"issue":"1","key":"5740_CR156","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s12325-015-0274-5","volume":"33","author":"A PETROV","year":"2016","unstructured":"PETROV A, PEREKHVATOVA N, SKULACHEV M, et al. SkQ1 Ophthalmic Solution for Dry Eye Treatment: results of a phase 2 Safety and Efficacy Clinical Study in the Environment and during challenge in the controlled adverse environment model [J]. Adv Therapy. 2016;33(1):96\u2013115.","journal-title":"Adv Therapy"},{"issue":"8","key":"5740_CR157","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1681\/ASN.2012121216","volume":"24","author":"S BIRK A V, LIU","year":"2013","unstructured":"BIRK A V, LIU S, SOONG Y, et al. The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with Cardiolipin [J]. J Am Soc Nephrol. 2013;24(8):1250\u201361.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"5740_CR158","doi-asserted-by":"publisher","first-page":"11087","DOI":"10.3390\/ijms160511087","volume":"16","author":"Z WANG","year":"2015","unstructured":"WANG Z, WANG J, XIE R, et al. Mitochondria-Derived reactive oxygen species play an important role in Doxorubicin-Induced platelet apoptosis [J]. Int J Mol Sci. 2015;16(5):11087\u2013100.","journal-title":"Int J Mol Sci"},{"issue":"0","key":"5740_CR159","first-page":"172","volume":"136","author":"FUENTESE ARAYA-MATURANA R","year":"2019","unstructured":"ARAYA-MATURANA R FUENTESE, URRA F A. Regulation of mitochondrial function as a promising target in platelet activation-related diseases [J]. Free Radic Biol Med. 2019;136(0):172\u201382.","journal-title":"Free Radic Biol Med"},{"issue":"21","key":"5740_CR160","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1111\/bph.16174","volume":"180","author":"L ROUBENNE","year":"2023","unstructured":"ROUBENNE L, LAISN\u00e9 M, BENOIST D, et al. OP2113, a new drug for chronic hypoxia-induced pulmonary hypertension treatment in rat [J]. Br J Pharmacol. 2023;180(21):2802\u201321.","journal-title":"Br J Pharmacol"},{"issue":"13","key":"5740_CR161","doi-asserted-by":"publisher","first-page":"e029131","DOI":"10.1161\/JAHA.122.029131","volume":"12","author":"READ A D","year":"2023","unstructured":"READ A D, BENTLEY R E T, MARTIN A Y, et al. Electron Leak from the Mitochondrial Electron Transport Chain Complex I at Site IQ is crucial for Oxygen sensing in rabbit and human ductus arteriosus [J]. J Am Heart Association. 2023;12(13):e029131.","journal-title":"J Am Heart Association"},{"issue":"0","key":"5740_CR162","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.freeradbiomed.2023.05.022","volume":"204","author":"MA WATSON","year":"2023","unstructured":"WATSON MA, BRAR H, GIBBS E T, et al. Suppression of superoxide\/hydrogen peroxide production at mitochondrial site IQ decreases fat accumulation, improves glucose tolerance and normalizes fasting insulin concentration in mice fed a high-fat diet [J]. Free Radic Biol Med. 2023;204(0):276\u201386.","journal-title":"Free Radic Biol Med"},{"key":"5740_CR163","doi-asserted-by":"crossref","unstructured":"FORTEZA-GENESTRA M A, ANTICH-ROSSELL\u00f3 M, RAMIS-MUNAR G, et al. Comparative effect of platelet- and mesenchymal stromal cell-derived extracellular vesicles on human cartilage explants using an ex vivo inflammatory osteoarthritis model [J]. Volume 12. Bone & Joint Research; 2023. pp. 667\u201376. 10.","DOI":"10.1302\/2046-3758.1210.BJR-2023-0109.R1"},{"issue":"0","key":"5740_CR164","first-page":"470","volume":"371","author":"W ZHANG","year":"2024","unstructured":"ZHANG W, CHEN G, CHEN Z, et al. Mitochondria-targeted polyprodrug nanoparticles induce mitochondrial stress for immunogenic chemo-photodynamic therapy of ovarian cancer [J]. J Controlled Release. 2024;371(0):470\u201383.","journal-title":"J Controlled Release"},{"issue":"15","key":"5740_CR165","doi-asserted-by":"publisher","first-page":"10043","DOI":"10.1021\/acs.chemrev.7b00042","volume":"117","author":"J ZIELONKA","year":"2017","unstructured":"ZIELONKA J, JOSEPH J, SIKORA A, et al. Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of Action, and therapeutic and diagnostic applications [J]. Chem Rev. 2017;117(15):10043\u2013120.","journal-title":"Chem Rev"},{"issue":"4","key":"5740_CR166","doi-asserted-by":"publisher","first-page":"S884","DOI":"10.3945\/ajcn.110.001917","volume":"93","author":"AUWERXJ FERNANDEZ-MARCOS P J","year":"2011","unstructured":"FERNANDEZ-MARCOS P J AUWERXJ. Regulation of PGC-1\u03b1, a nodal regulator of mitochondrial biogenesis [J]. Am J Clin Nutr. 2011;93(4):S884\u201390.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"5740_CR167","first-page":"168","volume":"181","author":"RUSSELL O M","year":"2020","unstructured":"RUSSELL O M, GORMAN G S, LIGHTOWLERS R N, et al. Mitochondrial Diseases: Hope Future [J] Cell. 2020;181(1):168\u201388.","journal-title":"Mitochondrial Diseases: Hope Future [J] Cell"},{"issue":"1","key":"5740_CR168","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev-pharmtox-010715-103155","volume":"56","author":"RM WHITAKER","year":"2016","unstructured":"WHITAKER RM, BEESON C C CORUMD, et al. Mitochondrial Biogenesis as a pharmacological target: a New Approach to Acute and Chronic diseases [J]. Annu Rev Pharmacol Toxicol. 2016;56(1):229\u201349.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"5740_CR169","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.kint.2023.01.026","volume":"103","author":"G DAGORN P","year":"2023","unstructured":"DAGORN P G, BUCHHOLZ B. A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of autosomal Dominant polycystic kidney disease [J]. Kidney Int. 2023;103(5):917\u201329.","journal-title":"Kidney Int"},{"issue":"1","key":"5740_CR170","doi-asserted-by":"publisher","first-page":"C66","DOI":"10.1152\/ajpcell.00357.2013","volume":"307","author":"V LJUBICIC","year":"2014","unstructured":"LJUBICIC V, BURT M. Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1\u03b1 axis [J]. Am J Physiology-Cell Physiol. 2014;307(1):C66\u201382.","journal-title":"Am J Physiology-Cell Physiol"},{"issue":"3","key":"5740_CR171","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/hmg\/ddr482","volume":"21","author":"S YATSUGA","year":"2012","unstructured":"YATSUGA S. Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice [J]. Hum Mol Genet. 2012;21(3):526\u201335.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"5740_CR172","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.2337\/diabetes.54.5.1392","volume":"54","author":"I BOGACKA","year":"2005","unstructured":"BOGACKA I, XIE H, BRAY GA, et al. Pioglitazone induces mitochondrial Biogenesis in Human Subcutaneous adipose tissue in vivo [J]. Diabetes. 2005;54(5):1392\u20139.","journal-title":"Diabetes"},{"key":"5740_CR173","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.16041","author":"Y CHENG","year":"2024","unstructured":"CHENG Y, HUANG P, ZOU Q, et al. Nicotinamide mononucleotide alleviates seizures via modulating SIRT1-PGC\u20101\u03b1 mediated mitochondrial fusion and fission [J]. J Neurochem. 2024. https:\/\/doi.org\/10.1111\/jnc.16041. Advance online publication.","journal-title":"J Neurochem"},{"issue":"1","key":"5740_CR174","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3892\/mmr.2020.11116","volume":"22","author":"J HUANG R X, TAO","year":"2020","unstructured":"HUANG R X, TAO J. Nicotinamide mononucleotide attenuates glucocorticoid\u2013induced osteogenic inhibition by regulating the SIRT1\/PGC\u20131\u03b1 signaling pathway [J]. Mol Med Rep. 2020;22(1):145\u201354.","journal-title":"Mol Med Rep"},{"issue":"4","key":"5740_CR175","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3233\/JAD-170988","volume":"62","author":"M REDDY P H, MANCZAK","year":"2018","unstructured":"REDDY P H, MANCZAK M, YIN X, et al. Synergistic Protective effects of mitochondrial division inhibitor 1 and Mitochondria-targeted small peptide SS31 in Alzheimer\u2019s disease [J]. J Alzheimers Dis. 2018;62(4):1549\u201365.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"5740_CR176","doi-asserted-by":"publisher","first-page":"32656","DOI":"10.1038\/srep32656","volume":"6","author":"E FILICHIA","year":"2016","unstructured":"FILICHIA E, HOFFER B, QI X, et al. Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson\u2019s disease model induced by MPTP [J]. Sci Rep. 2016;6(1):32656.","journal-title":"Sci Rep"},{"issue":"8","key":"5740_CR177","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s40279-018-0936-y","volume":"48","author":"C GRANATA","year":"2018","unstructured":"GRANATA C, JAMNICK N A BISHOPDJ. Training-Induced changes in mitochondrial content and respiratory function in human skeletal muscle [J]. Sports Med. 2018;48(8):1809\u201328.","journal-title":"Sports Med"},{"issue":"7","key":"5740_CR178","doi-asserted-by":"publisher","first-page":"a029694","DOI":"10.1101\/cshperspect.a029694","volume":"8","author":"RUEGSEGGER G N, BOOTH F W","year":"2018","unstructured":"RUEGSEGGER G N, BOOTH F W. Health benefits of Exercise [J]. Cold Spring Harbor Perspect Med. 2018;8(7):a029694.","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"11","key":"5740_CR179","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.3390\/nu16111725","volume":"16","author":"P DOBROSLAVSKA","year":"2024","unstructured":"DOBROSLAVSKA P, SILVA M L, VICENTE F, et al. Mediterranean Dietary Pattern for healthy and active aging: a narrative review of an Integrative and Sustainable Approach [J]. Nutrients. 2024;16(11):1725.","journal-title":"Nutrients"},{"issue":"8","key":"5740_CR180","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3390\/antiox12081643","volume":"12","author":"J S\u00e1NCHEZ-QUINTERO M J, DELGADO","year":"2023","unstructured":"S\u00e1NCHEZ-QUINTERO M J, DELGADO J, MART\u00edN CHAVESL, et al. Multi-omics Approach reveals prebiotic and potential antioxidant effects of essential oils from the Mediterranean Diet on Cardiometabolic Disorder using Humanized Gnotobiotic mice [J]. Antioxidants. 2023;12(8):1643.","journal-title":"Antioxidants"},{"issue":"34","key":"5740_CR181","doi-asserted-by":"publisher","first-page":"22840","DOI":"10.1074\/jbc.M109.032888","volume":"284","author":"RC NOLAND","year":"2009","unstructured":"NOLAND RC, KOVES T R, SEILER S E, et al. Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control [J]. J Biol Chem. 2009;284(34):22840\u201352.","journal-title":"J Biol Chem"},{"issue":"8","key":"5740_CR182","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/iub.1646","volume":"69","author":"I ADEVA-ANDANY M M, CALVO\u2010CASTRO","year":"2017","unstructured":"ADEVA-ANDANY M M, CALVO\u2010CASTRO I, FERN\u00e1NDEZ\u2010FERN\u00e1NDEZ C, et al. Significance of l\u2010carnitine for human health [J]. IUBMB Life. 2017;69(8):578\u201394.","journal-title":"IUBMB Life"},{"issue":"8","key":"5740_CR183","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.bbabio.2016.03.010","volume":"1857","author":"M ALC\u00e1ZAR-FABRA","year":"2016","unstructured":"ALC\u00e1ZAR-FABRA M, NAVAS P, BREA-CALVO G. Coenzyme Q biosynthesis and its role in the respiratory chain structure [J]. Biochim et Biophys Acta (BBA) - Bioenergetics. 2016;1857(8):1073\u20138.","journal-title":"Biochim et Biophys Acta (BBA) - Bioenergetics"},{"issue":"Suppl4","key":"5740_CR184","doi-asserted-by":"publisher","first-page":"S683","DOI":"10.33549\/physiolres.934712","volume":"70","author":"H RAUCHOV\u00e1","year":"2021","unstructured":"RAUCHOV\u00e1 H. Coenzyme Q10 effects in neurological diseases [J]. Physiol Res. 2021;70(Suppl4):S683\u2013714.","journal-title":"Physiol Res"},{"issue":"8","key":"5740_CR185","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41574-020-0365-5","volume":"16","author":"L KAZAK","year":"2020","unstructured":"KAZAK L, COHEN P. Creatine metabolism: energy homeostasis, immunity and cancer biology [J]. Nat Reviews Endocrinol. 2020;16(8):421\u201336.","journal-title":"Nat Reviews Endocrinol"},{"issue":"1\u20132","key":"5740_CR186","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cbi.2006.04.014","volume":"163","author":"F DEPEINT","year":"2006","unstructured":"DEPEINT F, BRUCE W R, SHANGARI N, et al. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism [J]. Chemico-Biol Interact. 2006;163(1\u20132):94\u2013112.","journal-title":"Chemico-Biol Interact"},{"issue":"0","key":"5740_CR187","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.arr.2016.10.005","volume":"39","author":"M MATTSON M P, LONGO V D, HARVIE","year":"2017","unstructured":"MATTSON M P, LONGO V D, HARVIE M. Impact of intermittent fasting on health and disease processes [J]. Ageing Res Rev. 2017;39(0):46\u201358.","journal-title":"Ageing Res Rev"},{"key":"5740_CR188","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.atherosclerosis.2019.11.021","volume":"292","author":"B O\u2019NEILL","year":"2020","unstructured":"O\u2019NEILL B. The ketogenic diet: pros and cons [J]. Atherosclerosis. 2020;292:119\u201326.","journal-title":"Atherosclerosis"},{"issue":"1","key":"5740_CR189","first-page":"84","volume":"119","author":"E MCGAUGH","year":"2022","unstructured":"MCGAUGH E. A review of ketogenic Diet and Lifestyle [J]. Mo Med. 2022;119(1):84\u20138.","journal-title":"Mo Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05740-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05740-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05740-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T05:03:35Z","timestamp":1732511015000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05740-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":189,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5740"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05740-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1057"}}